Liquid Extraction Surface Analysis Mass Spectrometry (LESA-MS) Novel Profiling Tool for Drug Distribution & Metabolism Analysis

Presented by: Dr. Daniel Eikel, Sr. Application Scientist – Advion, Inc.

Description: Liquid extraction surface analysis mass spectrometry (LESA-MS) is a novel mass spectrometry-based surface-profiling technique (Kertez, et al., 2009) that can be utilized in drug distribution and metabolism studies. Potential advantages of LESA-MS are as follows:

  • No radiolabeled compound is required
  • Its overall sensitivity appears favorable compared to autoradiography or matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI)
  • No additional sample preparation such as MALDI matrix application is required.

In this webinar, Dr. Daniel Eikel expands upon his publication (Henion, et al., 2011), discussing how LESA-MS can provide complementary information to the gold standards in this field: quantitative whole body autoradiography (QWBA) and whole organ LC-MS/MS, or other MS based approaches such as MALDI-MSI. He demonstrates how they have evaluated LESA-MS by studying the drug distribution and metabolism of terfenadine in mouse, and through direct comparison, proved that LESA-MS appears to be more informative than a comparable MALDI-MSI experiment and reflects the literature-known metabolism and distribution pattern for terfendine and its metabolite fexofenadine.

To download, please fill out the form below.

Advion respects your privacy. We will not give your email address to third parties or send you unwanted email.